| Name | Title | Contact Details |
|---|
First Impression Printing Co is a Chicago, IL-based company in the Business Services sector.
Techmedics® helps businesses get the most out of their technology investments by offering comprehensive IT support plans flexible enough for any sized business, in any industry. With locations across the US, Techmedics™ engineers are known for their expertise in infrastructure technology and consulting services. Founded in 1999 by Helen and James Moon, we have served over 400 companies around the world. Were focused on driving your technology forward while bringing your costs down. Give us a call with any questions you may have (877)-832-4180 or email info@techmedics.com.
Expertus is one of the leading providers in Business Services. It is based in Mountain View, CA. To find more information about Expertus, please visit www.expertus.com.
Celco is a Mahwah, NJ-based company in the Business Services sector.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.